Volume 5, Supplement 5, 2003 | MedReviews

<script language="JavaScript1.1" src="https://ad.doubleclick.net/ddm/adj/N9515.3206767MEDREVIEWS0/B22310636.252721090;abr=!ie;sz=728x90;ord=1;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=?"> <![CDATA[// ><!]]> </script>

Urology

Volume 5, Supplement 5, 2003

Volume 5, Supplement 5, 2003

Table of Contents

Supplement

Self-Assessment Post-Test

Herbert Lepor

Supplement

Herbert Lepor

Supplement

Clinical Evaluation of Benign Prostatic Hyperplasia

Kevin T. McVary

Supplement

5-Alpha-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia

Claus G. Roehrborn

Supplement

Long-Term Experience With 5-Alpha-Reductase Inhibitors

E. Darracott Vaughan

Supplement

Landmark Studies Impacting the Medical Management of Benign Prostatic Hyperplasia

Herbert Lepor

Supplement

The Medical Therapy of Prostatic Symptoms Study: What Will We Learn?

Kevin M. Slawin

Supplement

A Primary Care Physician's Perspective on Benign Prostatic Hyperplasia

Louis Kuritzky